Cubist Systematic Strategies, LLC Charles River Laboratories International, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 3,700 shares of CRL stock, worth $584,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,700
Previous 3,700
-0.0%
Holding current value
$584,822
Previous $728,000
6.18%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$973 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$804 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$345 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$286 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$285 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.04B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...